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Abstract
Background: MicroRNAs are a class of small RNAs known to regulate gene expression at the transcript level, the protein
level, or both. Since microRNA binding is sequence-based but possibly structure-specific, work in this area has resulted in
multiple databases storing predicted microRNA:target relationships computed using diverse algorithms. We integrate
prediction databases, compare predictions to in vitro data, and use cross-database predictions to model the
microRNA:transcript interactome – referred to as the micronome – to study microRNA involvement in well-known
signalling pathways as well as associations with disease. We make this data freely available with a flexible user interface as
our microRNA Data Integration Portal — mirDIP (http://ophid.utoronto.ca/mirDIP).
Results: mirDIP integrates prediction databases to elucidate accurate microRNA:target relationships. Using NAViGaTOR to
produce interaction networks implicating microRNAs in literature-based, KEGG-based and Reactome-based pathways, we
find these signalling pathway networks have significantly more microRNA involvement compared to chance (p,0.05),
suggesting microRNAs co-target many genes in a given pathway. Further examination of the micronome shows two distinct
classes of microRNAs; universe microRNAs, which are involved in many signalling pathways; and intra-pathway microRNAs,
which target multiple genes within one signalling pathway. We find universe microRNAs to have more targets (p,0.0001),
to be more studied (p,0.0002), and to have higher degree in the KEGG cancer pathway (p,0.0001), compared to intra-
pathway microRNAs.
Conclusions: Our pathway-based analysis of mirDIP data suggests microRNAs are involved in intra-pathway signalling. We
identify two distinct classes of microRNAs, suggesting a hierarchical organization of microRNAs co-targeting genes both
within and between pathways, and implying differential involvement of universe and intra-pathway microRNAs at the
disease level.
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Introduction
MicroRNAs are short, but important non-coding RNA sequences
that regulate gene expression [1]. They are thought to target the 39
Untranslated Regions (UTRs) of mRNA, disrupting their ability to be
translated into proteins, sometimes repressing the expression of the
mRNA itself [2,3,4,5,6,7,8,9]. MicroRNA prediction algorithms
generally pair the seed region of the microRNA (bases 2–8 from the
59end of the microRNA) to a cognate mRNA sequence. However, this
binding is complicated by many factors, not the least of which is that
imperfect microRNA:mRNA binding occurs, and thus single base-pair
mismatches and G:U wobble base-pairs must be considered.
Discovery of the first microRNA – lin-4 in worm (C. Elegans) [10], its
further characterization in 1989 [11], annotation as a non-coding
RNA in 1993 with a sequence complementary to the lin-14 39 UTR
[1,12], and functional characterization as having a translational
repression effect later that year [13] opened a rich research field. Many
subsequent in vitro experiments and computational predictions aimed at
uncovering microRNA:target relationships to fathom microRNA
e f f e c t so ng e n ee x p r e s s i o nr e g u l a t i o n .W i t ht h ed i s c o v e r yo fas e c o n d
nematode microRNA – let-7, which targets lin-41 and hbl-1, the
concept of microRNAs made the jump from worms to higher species,
since let-7 had well-known homologues even in humans [14,15,16].
Coining the term ‘‘microRNA’’ for this class of non-coding gene
regulators in three back-to-back Science papers in 2001 [17,18,19], the
discovery of microRNAs had crossed over to the human domain, and
finding microRNA targets became a high priority. After the first
bioinformatics attempt at predicting plant microRNAs [5], many
microRNA prediction algorithms, for both fly (D. melanogaster)a n d
human (H. sapiens), were developed [20,21,22]. More than 10 public
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all using different algorithms and approaches. Considering varying
degrees of sequence similarity, conservation, site accessibility and
different targeted regions of the mRNA – all databases add a novel
level of complexity to the microRNA question [20,23,24,25,26,27,28,
29,30,31,32,33,34,35,36,37,38,39,40].
To visualize and analyze these complex relationships between
different predictions of microRNA:mRNA target mappings, we
borrow ideas from protein-protein interactions and gene regula-
tory networks. We first integrate all databases into a freely
available data portal – mirDIP (microRNA Data Integration
Portal) – and use NAViGaTOR (Network Analysis, Visualization
and Graphing Toronto) [41] to analyze and visualize the resulting
network of microRNA:mRNA target mappings – the microRNA
interaction network (micronome).
Results and Discussion
Characteristics of microRNA predicting databases
There are many characteristics of microRNA:mRNA target
binding that are taken into account - in different combinations -
for each microRNA prediction database. We begin with a review
of these criteria. Table 1 shows all databases considered in this
research. To enable more informed integration of these predic-
tions, we consider characteristics of individual microRNA predic-
tion algorithms in detail, and summarize them in Table 2. All
eleven main groups of features used for prediction are described
below:
(1) Seed Sequence match. All prediction algorithms depend on this
criterion. Allowing for base-pair mismatches and G:U
wobbles, which have been shown to be important in
microRNA binding [42], prediction algorithms look for
high degree of complementarity between the 59 end of the
microRNA and the 39 end of the mRNA target sequence.
Particular attention is paid to the seed region (bases 2–8 from
the microRNA 59 end).
(2) Conservation. Many prediction algorithms take into account
the conservation of the microRNA binding sequence in the
mRNA target. Generally used as a filtering step, a highly
conserved target site is thought to produce a more reliable
prediction. Conservation is not directly used in some
databases (Probability of Interaction by Target Accessibility
(PITA)) [30,34], is not directly incorporated into the score in
others (Targetscan) [24,27,33], and is not used at all in
others (RNA22) [34]. Interestingly, PITA results suggest that
considering site accessibility is analogous to considering
conservation, since accessible 39 UTR microRNA binding
sites tend to fall in conserved regions [30]. To reduce bias in
our analyses, we use both predictions with and without
conservation.
(3) Free Energy of microRNA:mRNA duplex. The Free Energy of the
microRNA:mRNA duplex (DG), is often calculated with the
Vienna Folding package [43,44,45] or RNA hybrid [46]. It
evaluates the energy required for the formation of the
microRNA:mRNA duplex from a completely dissociated
state – a more negative value indicates a larger inclination
for the two RNAs to bind.
(4) Site accessibility. Site accessibility is not considered in many
prediction algorithms. Measured as DDG for use in PITA, it
compares the energy requirement for the already folded 39
UTR to unfold to allow the microRNA accessibility to the
target site, and to refold into the microRNA:mRNA duplex
[30]. A more negative DDG indicates a favourable folding
energy for the microRNA:mRNA configuration.
(5) Contribution of multiple binding sites. Many algorithms reward
microRNAs that have multiple binding sites within the 39
UTR of a particular gene, reasoning that the microRNAs
will be able to exert a dose-dependent effect on target
expression. Binding sites can be for a single microRNA or for
multiple different microRNAs that show co-operativity
resulting in synergistic gene repression [47]. Several studies
have shown that the ideal inter-binding site distance falls
between 8–40 base-pairs [27,48].
(6) Local ALU content. ALU sequences are segments of repetitive
DNA interspersed within the human genome, thought to
have arisen through retro-transposons and so named
because they can be cleaved by the restriction enzyme
Alu1 (reviewed in [49]). Considered in Targetscan’s context
score, Grimson et al. have shown that an enrichment of A or
U base-pairs in the 30 nucleotides up or downstream of the
microRNA binding site in the 39 UTR tends to favorably
associate with repression in target expression [27,33].
(7) Local mRNA sequence. The consideration of sequence sur-
rounding the microRNA binding site on the 39 UTR is
sometimes taken into account. Algorithms may examine
local sequence effect on site accessibility, or examine
sequence content for particular nucleotides [27,30,33].
(8) Ribosomal shadow. Considered in Targetscan, the 15 nucleo-
tides after the stop codon in a 39 UTR form poor microRNA
target binding sites that show little ability to repress
expression. It has been postulated that this is due to a
ribosomal shadow effect [27].
(9) Uses miRanda. miRanda [20,29] is the first microRNA
alignment algorithm, is similar to the Smith-Waterman
algorithm for sequence alignment and uses rules of thumb
previously established in sequence alignment [50,51,52]. It
forms the basis of several microRNA prediction algorithms.
miRanda considers several features described below:
Table 1. MicroRNA Prediction Databases.
Database Details
Mapped
Interactions MicroRNAs
Unique
Mapped
Targets
Targetscan Conservation 189,075 675 16,512
Targetscan No Cons. 1,457,484 677 17,678
RNA22 39 UTR 264,630 313 14,949
RNA22 59 UTR 53,405 313 7,333
RNA22 CDS 487,110 313 19,766
Microrna.org Conservation 956,664 677 16,875
mirBase Conservation 568,099 711 21,111
PITA Top Hits 208,937 677 10,143
PITA* All Hits 4,010,548 677 16,942
PicTar* 4-way 56,229 178 6,792
PicTar 5-way 17,224 129 2,534
microT
$ v3.0 1,434,406 555 17,585
*Not used in all comparisons, nor the construction of microRNA interaction
networks since it is a superset of the top database predictions.
$Not used in all comparisons, nor the construction of microRNA interaction
networks since it was not available for bulk download at the time of data
curation.
doi:10.1371/journal.pone.0017429.t001
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match, +2 for G:U wobble. A penalty of 22 for a Gap
Extension and 28 for a Gap Opening. The cutoff for S, the
result of these sequence matches is generally S.80 (flies),
S.50 (humans).
N Scaling – Matches in positions 1–11 of the microRNA (from
the 59 end) are given twice the weight of matches elsewhere
to reflect the asymmetry of microRNA binding [29].
N Four empirical rules:
N No mismatch in bases 2–4;
N ,5 mismatches in bases 3–12;
N At least 1 mismatch in bases 9 to (Length-5);
N ,2 mismatches in the final 5 base-pairs.
N Vienna Package Folding assumes the microRNA is linked to
the 39 UTR by 8 –x– base-pairs that cannot bind anything.
This single structure is then folded. The DG cutoff is usually
set as DG,214 kcal/mol for flies and DG,217 kcal/mol
for humans.
(9) The final score is the total energy and total score of all hits
between those of a microRNA and a 39 UTR.
N Conservation – a filtering step requiring 90% conservation
or more between human and rat or mouse and 80%
conservation between D. melanogaster and D. pseudoobscura or
A. gambiae.
(10) Position effects. Positional effects reward microRNA target sites
that fall within the first quartile of the 39 UTR after the stop
codon (+15 base-pairs) or within the final quartile of the 39
UTR, near the poly(AAAA) tail. This effect is more
pronounced in long UTRs [27].
(11) 39 Pairing. Aside from strong seed region pairing, many
algorithms that aren’t based on miRanda also require nucleotide
binding between the microRNA and the target mRNA between
bases 12–17 of the 39 end of the microRNA [27].
MicroRNA prediction database similarities
Since microRNA:mRNA target prediction algorithms use
different combinations of features to perform the same task, it is
useful to analyze the distribution of these predictions across
databases. There is an expected trend – with far fewer predictions
being made that transcend six or more databases than those that are
present in just one database. We count over 2 million predictions
present in only one database, falling off to a surprisingly small 18
predictions identified in 8 of the 9 databases considered (As
indicated in Table 1, we do not consider PITA All Targets nor
picTar 4-way in this part of our analysis to avoid double-counting.
Nor do we consider microT, since bulk download was not available
at the time of data curation) (Figure 1A). Figure 1B compares all
database predictions to microRNA.org – indicating that although
we see low total overlap among all databases, in reference to the
largest conservation-considering database there is considerable
similarity between at least five database prediction schemes.
Although DIANA microT v3.0 [39,40] was not included in our
extended database analysis and comparison, since it was not
available for bulk download when our study began, we have
included it in this figure for the sake of comparison.
Although most databases consider conservation, they each handle
it differently. Bartel’s Targetscan publishes dual lists of targets based
on either conserved or non-conserved sites. Thirty-one percent of
these microRNA:mRNA target predictions are shared by both lists
(Figure 1C, left panel), demonstrating that there is a strong tendency
for genes to contain both conserved and non-conserved microRNA
binding sites along the length of their 39 UTR. On the other hand,
picTar considers grades of conservation in their prediction algorithm.
Publishing both a 4-way and 5-way conservation scheme (human,
mouse, rat, dog vs. human, mouse, rat, dog, chicken) picTar suggests
degreeofconservationcorrelateswithrobustnessofprediction.Inthis
case we can see that one list is clearly a subset of the other, and
moving from a less conserved setting to a more conserved setting
reduced the number of predicted targets by 30% (Figure 1C, right
panel). When combining datasets, Figure 1D shows the percentage of
predictions preserved per prediction scheme when requiring a
microRNA:mRNA target prediction to occur in at least three
Table 2. Characteristics of MicroRNA Prediction Databases.
Targetscan
Conserved
Targetscan
Non-
Conserved
RNA22
39 UTR
RNA22
59 UTR
RNA22
CDS
micro-
RNA.
org
microCosm
(formerly
mirBase)
PITA
Top Hits
PITA
All Hits
picTar
4-way
picTar
5-way
DIANA
microT
Conservation X
* XX
11 XXX
Site Accessibility XX
Local AU content X X
Multiple Binding Sites
(1 microRNA)
X X XX X X XXX
Multiple Binding Sites
(.1 microRNA)
X
¥ X
¥
Uses miRanda X X
Free Energy of Duplex X X X X X X X
Examines surrounding
Sequence
XX X X
Weighted 59 end or
considers seed type
XX X X X
*Targetscan Conserved uses conservation, but it is not integrated into the context score.
1PITA does not explicitly use conservation in scoring targets. However, accessible microRNA binding sites tend to show high conservation.
¥picTar does have predictions for multiple microRNAs binding to a single 39 UTR; however, that data was not used in this study.
doi:10.1371/journal.pone.0017429.t002
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interactions after applying this filter.
Comparing microRNA prediction databases to the truth
MicroRNA target filtering is vital. To examine whether a
combination of microRNA prediction databases would outperform
any one source, data from 15 publicly available microRNA over-
expression/knockdown experiments followed by microarray [53,54,
55,56,57,58,59,60,61] was assembled (Table 3). As discussed in the
Methods section, when comparing microRNA target predictions to
actual microRNA targets (as determined by microarray experi-
ments) two filtering steps were performed to increase the suitability
Figure 1. MicroRNA prediction database characteristics. Panel A: Distribution of microRNA:target predictions by number of predicting databases.
Panel B: Overlap of microRNA prediction databases with microRNA.org. Panel C: Overlap of microRNA prediction databases Targetscan and picTar, sinceb o t h
consider degree of conservation as part of their scoring scheme. Panel D: Percentage of overlapping microRNA predictions across two or more databases.
doi:10.1371/journal.pone.0017429.g001
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and by cell type. Filtering by microarray (Table 3 column 3)
eliminates targets not present on the particular chip in the
experiment, and thus having no chance of appearing in the final
target set. Filtering by cell type (Table 3 column 4) eliminates genes
expressedat only lowlevels inthecellline (whichwould reducetheir
chances of showing a knock-down effect). This two-step filtering
drastically changes the predictions. As illustrated in Figure 2A,
beginning with an identical set of mir-1 predicted targets across all
databases and filtering by cell type and chip type to make the target
predictions suitable for comparison to 2 different experiments
results in significantly different final prediction sets – with
overlapping targets numbering only 60% of the sets – clearly
demonstrating the need to tailor predictions to the setting in which
the experiment was done before any comparisons are undertaken.
This filtering exercise shows how critical it is to consider tissue
specificity when examiningmicroRNAsof interest.Clearly, with the
availability of more in vitro and in vivo data, it will become crucial to
ensure that data is organized in a tissue-specific manner to enable
more accurate modelling of the interactions present in particular
settings.
High-throughput target validation experiments are not
always in agreement. Ideally, high-throughput experiments
would provide clear and concise answers in simple over-expression
experiments. Unfortunately, we have not found that to be entirely
the case. Examining the filtered results for the 2 microRNAs with
high-throughput experimental results by multiple groups – there is
remarkably little overlap between reported targets. Using mir-124
over-expression as an example, comparing the Baek et al. [53],
Lim et al. [57] and Wang et al. [60] data sets – at the least
stringent confidence level for targets, allowing the overlap between
experiments to be maximal – we see only 10 common targets
between all 3 lists, 3.7% of the smallest target list (Figure 2B).
Expanding the overlap to include ‘‘true’’ targets predicted on 2 in
vitro lists improves the situation, yet covers less than 50% of the
smallest dataset. Similar results are seen in duplicate mir-1
experiments putting the overlap at 8%. One possible explanation
for such observations is over-dosing with transfections, resulting in
deregulation of gene expression due to a massive influx of
microRNA molecules [62].
Comparing predictions to ground truth. PITA Top
Targets, picTar 5-way Conservation and TargetScan Conserved
Targets are all suitable candidates for top microRNA prediction
database. Not only do they retain many predictions passing
through a filter requiring predictions to be present in 3 or more
databases (79%, 64%, 57% respectively) (Figure 1D), they also
perform well when evaluating database performance on both
precision and recall when compared to publicly available high-
throughput microarray data (Figure 2C). While all three databases
have many retained cross-database predicted targets, PITA and
Targetscan Conserved do tend to outperform picTar 5-way when
both precision and recall are considered – that is, when we require
database prediction sets to not only contain many true positives,
but also to predict many of the actual true targets. Examining the
least stringent in vitro ‘‘ground truth’’ data: PITA Top Targets,
picTar 5-way Conservation and Targetscan Conserved have
precision and recall values of: 30%, 9%; 38%, 2%; 32%, 12%
respectively. This demonstrates that although many of picTar 5-
way’s predictions are true, it performs exceptionally poorly when
measuring the number of real targets that picTar actually predicts.
In the balance between precision and recall one might suggest
using these databases as follows: 1) when looking for confirmatory
evidence of a particular interaction between a microRNA and a
specific target – it is better to use a database with superior recall
such as Targetscan Conserved, Targetscan Non-Conserved or
microCosm (formerly mirBase), which are more likely to include a
target prediction if one exists; 2) when identifying any possible
target for a particular microRNA to form the basis for in vitro or in
vivo experiments, it would be best to consult picTar 5-way; 3) when
finding in silico evidence for an interaction of a microRNA and a
gene of a certain family or function, it is best to use a database with
a more even balance between precision and recall such as PITA
Top Targets.
Comparing predictions to Tarbase. Tarbase [63], curated
bytheDIANALab,providesarunninglistofmicroRNAinteractions
that have been shown to be true or false by either microarray
experiments, pSILAC experiments or some other manner of specific
probing for a particular microRNA:target interaction. Although
Tarbase does not represent a non-biased list of microRNA targets, it
is interesting to compare our list of 2+DB microRNA interactions to
those present in their database. Thirty-nine percent of Tarbase-
reported True mRNA repression targets, 48% of Tarbase-reported
True mRNA cleavage targets, 67% of Tarbase-reported targets of
unknown effect, 32% of Tarbase-reported pSILAC tested interac-
tions and 62% of Tarbase-reported microarray tested interactions
were present in our 2+DB set of interactions.
Since microRNAs act through translational inhibition more
frequently than they do through mRNA degradation, it is obvious
that examining microarray data is not the perfect setting in which
to evaluate microRNA targets. The subset of targets that have
been transcribed but not translated will still be expressed in the
data and as such they will be missed. However, it has been shown
that proteins repressed by more than 30% also tend to destabilize
at the transcript level [53] – meaning that examination of
expression levels is a reasonable surrogate for large translational
repressions. Another possible source for incorrect predictions
includes off-target effects. MicroRNA overexpression is thought to
produce some false positives, perhaps due to dosage issues [62].
However, these off-target effects will occur less frequently than in
synthetic siRNA overexpression systems.
Table 3. Characteristics of High-throughput Experiments.
Study microRNA Platform Cell Type
Lim et al., 2005 hsa-mir-1 Rosetta 25 k v2.2.1 HeLa
Baek et al., 2008 hsa-mir-1 Agilent Whole
Genome 4644 k
HeLa
Linsley et al., 2007 hsa-mir-106b Rosetta/Merck 44 k 1.1 HeLa
Lim et al., 2005 hsa-mir-124 Rosetta 25 k v2.2.1 HeLa
Wang et al., 2006 hsa-mir-124 Affymetrix U133 plus2 HepG2
Baek et al., 2008 hsa-mir-124 Agilent Whole
Genome 4644 k
HeLa
Ceppi et al., 2009 hsa-mir-155 Affymetrix U133 plus2 MDDS
Linsley et al., 2007 hsa-mir-16 Rosetta/Merck 44 k 1.1 HeLa
Baek et al., 2008 hsa-mir-181 Agilent Whole
Genome 4644 k
HeLa
Gennarino et al., 2009 hsa-mir-26b Affymetrix U133 2 HeLa
Tavazoie et al., 2008 hsa-mir-335 Affymetrix U133 plus2 LM2
Huang et al., 2008 hsa-mir-373 Wistar Illumina V6 MCF-7
Huang et al., 2008 hsa-mir-520c Wistar Illumina V6 MCF-7
Webster et al., 2009 hsa-mir-7 Affymetrix U133 plus2 A549
Gennarino et al., 2009 hsa-mir-98 Affymetrix U133 2 HeLa
doi:10.1371/journal.pone.0017429.t003
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PLoS ONE | www.plosone.org 5 February 2011 | Volume 6 | Issue 2 | e17429Figure 2. MicroRNA target prediction processing and evaluation. Panel A: Identification of microRNA targets is highly dependent on the
experimental setup. Filtering by cell type and microarray platform on an identical initial prediction set can cause a divergence of up to 40% in the
final target lists. Panel B: MicroRNA over-expression in different experimental settings results in poor overlap of identified targets. Venn diagram of
discrepancy between in vitro microRNA over-expression experiments of mir-124. Panel C: Comparison of precision and recall across microRNA
prediction databases, measured by computing the average values for all microRNA predictions by a particular database compared to their matched
low stringency ‘‘ground truths’’. Panel D: The percentage of remaining predictions by considering overlap across 2, 3, 4, and 5 prediction databases.
Panel E: Precision measurements for microRNA:target predictions by number of prediction databases, indicating the percentage of predicted targets
that were shown to be true across in vitro experiments. Stringency levels refer to confidence in the microarray data and were determined by either
p-value or percentage knockdown as discussed in the methods. Panel F: Recall measurements for microRNA:target predictions by number of
mirDIP Identifies Pathway-Specific MicroRNAs
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experiments are exciting new techniques that are emerging at
the forefront of microRNA target research, and which allow the
direct comparison of the proteomes of two different samples.
Although an improvement on expression analyses for microRNA
target research, examinations at the protein level will still suffer
from the inability to distinguish primary from secondary effects.
Furthermore, they are neither as high-throughput as expression
analyses nor as time-efficient to run, and the set-up costs to
run mass spectrometry experiments are far higher than micro-
arrays at the present time. Optimal microRNA target analysis
would require experiments where it can be shown that actual
microRNA:mRNA binding is occurring with an associated
reduction in mRNA or protein expression. Only then could we
be certain an interaction is occurring – and such high-throughput
experiment series remain a future challenge.
Integrating prediction databases in mirDIP. Due to the
massive amount of genomic information being deciphered on a
daily basis, there is an inevitable bottleneck between
computational prediction and identification of binding sites, and
the in vitro or in vivo validation of such interactions. Clearly, it
would be useful to be able to prioritize microRNA:mRNA target
predictions to reduce excessive false leads and unnecessary
experiments. It has been previously shown, and confirmed here
that none of the microRNA prediction databases does a perfect job
of target identification [53,64], although they are all suitable to
provide an initial prediction. Integrating multiple databases
improves accuracy or coverage of predictions by balancing out
the precision and recall. Comparing microRNA predictions made
by a minimum of either two or three databases to all truth files,
enables us to retain 24% and 8% of filtered target predictions
(Figure 2D), and obtain precision and recall values of 25%, 19%;
29%, 11% respectively (Figures 2E, 2F), providing a more
balanced precision:recall ratio.
To enable this analysis, we introduce mirDIP – the microRNA
Data Integration Portal – a free and publicly available data portal
integrating up-to-date microRNA target predictions from eleven
individual source prediction databases [20,23–35]. Similar to our
Interologous Interaction Database (I2D) maintenance program,
we will update it at minimum twice a year to ensure that the latest
microRNA:target prediction data from all sources is available to
users. Importantly, to ensure consistency and enable accurate re-
analysis in the future using new and older data, we keep track of
versions of individual resources, and all mirDIP releases will be
able to search the most current, or older versions.
Similar to mirGator, which amalgamates three microRNA
databases (miRanda, picTar and TargetScan) with expression data
while also providing enrichment analysis [65], mirDIP allows the
user to take more control over the prediction data that they
consider. Not only does our resource conveniently integrate eleven
different prediction databases in one place, it allows users to
choose which combinations of databases they would like to
consider – refining options by database or by database charac-
teristics – when selecting prediction data. This empowers users to
capitalize on their knowledge of the workings of different
databases, compensating for strengths and weaknesses of individ-
ual databases – choosing to focus on schemes considering different
variables to create a customized prediction set based on the user’s
preferences and tailored to application-specific tasks, taking into
account the need for either high precision or high recall as
discussed above. File S1 introduces the mirDIP interface (Figure
S1) and describes several search scenarios. Figures S2, S3, S4, S5
display screenshots of the mirDIP search parameters. Finally, in
the sections that follow, we describe how mirDIP can be used
along with NAViGaTOR [41] – a scalable, network analysis and
visualization system – to perform novel microRNA:target predic-
tion visualization.
Construction of microRNA interaction networks
For the construction of microRNA interaction networks based
on gene signalling pathways, we have refrained from using only
targets from in vitro or in vivo experiments due to the obvious bias
present in such data. Rather, we have chosen to use interactions
appearing at two different confidence levels – those present in at
least 2, or at least 3 microRNA prediction databases (2+DB,
3+DB) as a threshold for robust microRNA:target predictions.
Further, drawing from nine of the twelve databases indicated in
Table 1 to determine the 2+DB and 3+DB datasets (eliminating
the risk of double-counting by omitting the PITA All Targets and
picTar 4-way databases and not including microT), we draw from
4/9 databases using conservation as a target site algorithm
criterion and 5/9 databases not considering it. As such, we ensure
that the requirement of sequence conservation does not influence
the construction of microRNA networks in either direction.
Beginning with the well-known Phosphoinositide 3-Kinase
(PI3K) pathway, we examined two aspects of this pathway with
respect to microRNA involvement, garnering our pathway
information from reviews discussing member-genes [66,67,68,69].
PI3K subunit regulation. To examine the relevance of
mapping microRNAs into signalling pathways, we chose to
examine 2 separate coordinate signalling scenarios in the PI3K
pathway. Well known for its control of a broad range of down-
stream effector genes, the PI3K pathway is involved in cell growth,
proliferation, differentiation, cell death, motility and survival.
Implicated in many cancers, not only does it count as members
many oncogenes, at the top of the pathway lies the most potent
breast cancer oncogene known to date – receptor tyrosine kinase
HER2 (also known as ERBB2) – a key receptor at the top of the
signal transduction chain.
The PI3K family is divided into 3 classes. Members of each class
of PI3K molecules comprise 2 subunits – a regulatory subunit and
a catalytic subunit. These subunits are distinct proteins coded in
different regions of the genome as either distinct genes or splice
variants transcribed out of a similar locus producing translated
proteins of varying sizes. The particular assembled combination of
the 2 subunits of PI3K determine the molecule’s structure and
function, and varying combinations of subunits are active in
entirely different cellular settings [69]. Using interactions at the
3+DB robustness level, we map the microRNAs targeting genes
involved in the assembly of Class 1 PI3K (Figure 3). Immediately,
it becomes evident that the possibility for PI3K subunit regulation
at a post-transcriptional level is real. The network resulting from
the input of all Class 1 PI3K subunit genes (PIK3CA/B/C/D,
PIK3R1/2/3/4/5/6) contains five primary nodes (the other
subunit genes are missing due to the lack of microRNAs targeting
them in a sufficient number of databases), 181 secondary nodes
and 206 interactions. Permutation analysis of randomly selected 5-
node networks confirmed that this provides a significant
prediction databases, indicating the percentage of in vitro targets covered by predictions. Stringency levels refer to confidence in the microarray data
and were determined by either p-value or percentage knockdown as discussed in the methods.
doi:10.1371/journal.pone.0017429.g002
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network. The most striking feature of the network is the
participation of primary nodes in interactions with at minimum
two other nodes – indicating that this network is significantly more
connected through microRNAs than one would expect by chance
alone (p,0.01).
Regulation of PI3K signalling. To further examine
microRNA involvement in this pathway, we use a model of the
downstream signalling components of this pathway as indicated in
a recent review [66]. Here we unveil a second highly-connected
microRNA network (Figure 4) (based on 2000 permutations:
p,0.05 for number of nodes in the network, p,0.05 for number
of interactions in the network, p,0.05 for number of nodes with
degree $4). It is quite surprising to see the number of microRNAs
that can co-target potent tumour suppressors and oncogenes. We
find a microRNA – hsa-mir-19b – that concurrently targets
PTEN-TSC1-PI3KCA-TP53, and others that co-target RPS6-
KB1-PDK1-TSC1-PTEN and PTEN-RPS6KB1-FOXO3-TSC1.
In addition, there are many microRNAs that target pairs of
elements of this pathway: 15 microRNAs target RPS6KB1 and
PTEN, 8 microRNAs target both RPS6KB1 and TSC1, and 4
microRNAs target both EIF4E and RPS6KB1. Clearly, we are
only beginning to understand the level of regulation possible with
microRNAs co-targeting many different genes, but it is becoming
increasingly evident that this level of network complexity governs
some interesting and previously hidden relationships between
potent oncogenes and tumour suppressors in the cell.
Examination of KEGG and Reactome pathway-based
microRNA networks
Basic Network Parameters. After initially testing our
hypothesis on the PI3 Kinase pathway, we decided to undertake
a more extensive and rigorous examination of signalling pathways
within the cell. Since pathway definitions have not been
unanimously settled and there is still much debate as to which
resource defines a signalling pathway most accurately and
comprehensively, we decided to use pathways delineated by the
Kyoto Encyclopedia of Genes and Genomes database (KEGG)
[70,71] and pathways defined by the Reactome [72,73,74]
database to further support the microRNA networks built based
on expert-curated pathway reviews in the previous section.
Examining interactions predicted at 2 threshold levels: 2+DB
and 3+DB, we created microRNA networks for both the canonical
signalling pathways and for 2000 permutations of pathways
created with the same number of primary node genes. Our
findings showed a similar trend for most interaction sets and
signalling pathways that we examined. We found that true
signalling pathways tend to involve more microRNAs and
contain more interactions, as well as having more high degree
nodes (degree $4) than pathways created out of a random set of
starting nodes. We examined 9 KEGG pathways and 12
Reactome pathways at the 2+DB and 3+DB interaction
thresholds. The pathways with the lowest average p-values (that
is the average of p-values across the 4 measured parameters -
number of network interactions, number of network microRNAs,
Figure 3. MicroRNA interaction network for assembly of PI3K subunits. Mapping PI3K subunits to microRNA interactions produces a
network that is significantly more connected than at random (p,0.05). Green nodes are regulatory subunits and yellow nodes are catalytic subunits.
doi:10.1371/journal.pone.0017429.g003
mirDIP Identifies Pathway-Specific MicroRNAs
PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e17429number of network nodes with degree $4 and network density)
were KEGG pathways: ERBB signalling pathway (hsa04012)
(2+DB), mTOR signalling pathway (hsa04150) (2+DB), Wnt
signalling pathway (hsa04310) (2+DB), MAPK signalling pathway
(hsa04010) (3+DB) and Pathways in cancer (hsa05200) (3+DB) with
average p-values of p,0.0006, p,0.0009, p,0.002, p,0.002,
p,0.007, respectively (Figure 5). Of the pathways described in both
the KEGG and Reactome databases (NOTCH, VEGF and WNT),
WNT results were the least conserved across both databases –
showing significance in KEGG (average p-values of p,0.002 and
p,0.036 for 2+DB and 3+DB respectively), but not in Reactome
(average p-values of p,0.64 and p,0.68 for 2+DB and 3+DB
Figure 4. MicroRNA interaction network for elements of the PI3K pathway. Mapping the elements of the PI3K pathway based on a
literature review [66], produces a network where many genes are targeted by common microRNAs suggesting a novel microRNA role of pathway
regulation.
doi:10.1371/journal.pone.0017429.g004
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likely to be consistent across the two databases (average p-values of
p,0.102 and p,0.105 for 2+DB and 3+DB respectively in KEGG
and average p-values of p,0.256 and p,0.139 for 2+DB and
3+DBrespectivelyinReactome).Wefoundthatsomepathwayshad
greater tendencies than others to show significance – for example
the FGFR and Cell Cycle Genes pathways (which, it could be
argued, is not a signalling pathway and hence does not fit within this
study and hence acts as our negative control) described only by the
Reactome database had a tendency towards higher p-values than
other pathways examined (Reactome FGFR pathway average p-
values of p,0.35 and p,0.4 for 2+DB and 3+DB respectively and
Reactome Cell Cycle Genes average p-values of p,0.78 and
p,0.45 for 2+DB and 3+DB respectively). The measured
parameters found to be most frequently significant across all
studied scenarios were the number of microRNA nodes in the
network with degree $4 (significant at p,0.05 in 30/42 tested
scenarios), and the number of total microRNA:target interactions in
the network (significant at p,0.05 in 27/42 tested scenarios). As
highlighted in Figure 5 – one can find enrichments that are
supported by both pathway databases, while other enrichments are
highlighted in the analysis using one or the other pathway database.
Examining expert-curated pathways, KEGG pathways and
Reactome pathways with similar findings gives us confidence that
this phenomenon is in fact real.
Centrality Measures. We further examined network
betweenness centrality (using Brandes’ algorithm [75] in R [76]
using the RBGL package [77,78]) as well as the average
betweenness centrality of the top 10 genes and microRNAs by
degree, and the average shortest path length between the top 10
genes. In general, these measures were not found to be
significantly different in true signalling pathways from the
random networks across most pathways. For the KEGG 3+DB
signalling pathways network betweenness centrality – a measure of
the difference between the node with the highest betweenness
centrality (the node on the most shortest paths) to all other nodes
in the network – we did see a small trend towards pathway
networks having lower betweenness centrality (p,0.0001 (WNT
pathway) to p,0.837 (VEGF pathway). This trend suggests that
true signalling pathways have a more balanced centrality structure
with fewer ‘‘hub’’ nodes than random networks do. However, we
did not see any difference in the betweenness centrality of the top
ten microRNAs by degree or the top ten genes by degree in the
signalling pathways (p,0.089 to p,0.687 for microRNAs and
p,0.37 to p,0.987 for genes). Further, due to the distributions of
the network values for average and maximum shortest paths
(measured with Dijkstra’s algorithm [79]) between the top 10
genes we were unable to conclusively evaluate these parameters
(95% of average shortest path values were 3 and almost 75% of
maximum shortest path values were infinite). This lack of
Figure 5. MicroRNA interaction network characteristics. Examination of four microRNA interaction network characteristics across well-known
signalling pathways using KEGG (panels A and B) and Reactome pathway databases (panels C and D). Signalling pathways tend to be enriched for the
number of microRNAs, the number interactions and the number of high degree nodes mapped.
doi:10.1371/journal.pone.0017429.g005
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the fact that we did not model interactions between proteins in our
networks, choosing to examine only interactions between genes
and microRNAs. Thus, our networks tended to have a particular
structure requiring all pathways to alternate between gene and
microRNA due to the lack of protein-protein connections.
Integration of protein-protein interactions with microRNA-target
interactions in a network could be re-examined at a later date.
Network Hubs. We also examined the possibility that hubs
in these microRNA networks might be more likely to be date or
party hubs as defined in Han et al.’s paper [80]. Using our I2D
database [81,82] we examined known human protein-protein
interactions for a binomial distribution to define such hubs, and
failed to find such a distribution, hence we are unable to further
study any such relationship.
Universe and Intra-pathway microRNAs. Upon realizing
that microRNAs play a large role within signalling pathways – we
produced a road map to delineate the inter-pathway connections
(Figure 6). It quickly became clear that there are distinct classes of
microRNAs. Examining microRNAs with degree greater than two
in any signalling pathway, we were able to identify 77 microRNAs
that act only in an intra-pathway manner, affecting multiple
targets but only within one single pathway. These microRNAs
tend to target the ERBB, mTOR, MAPK, WNT and Jak-STAT
pathways and no intra-pathway microRNAs appear to target the
VEGF, NOTCH and PI3K pathways. We further identified 61
microRNAs targeting all 8 KEGG pathways that we examined at
the 3+DB level. In attempts to validate this classification of
microRNAs into intra-pathway and universe classes, we went to
the literature. Searching for total PubMed articles, we see a
significant difference between universe and intra-pathway
microRNAs (p,0.0002) – with universe microRNAs discussed
more frequently (Figure 7A). Further, the most discussed
microRNAs, hsa-mir-15a, hsa-mir-16 and hsa-mir-34a have high
degree in the many pathways in which they are involved (hsa-mir-
15a has intra-pathway ranking of 2(ERBB), 1(Jak-STAT),
2(MAPK), 3(VEGF), 4(mTOR), 1(WNT), 27(NOTCH)). This
observation makes sense when one considers that many decisions
regarding the selection of microRNAs to study are based on high-
throughput experiments, through over-expression of a library of
microRNAs and examination of several simple read-out
conditions. It follows that microRNAs with involvement in many
pathways – universe microRNAs – might be able to produce large
changes within the cell, resulting in measurable outcomes
compared to controls. As such, these microRNAs might be
selected for further study, resulting in more PubMed articles.
When constructing the microRNA road map from known
signalling pathways in KEGG, we did not include the Pathways
in Cancer gene network, since it is not a signalling pathway in its
own right. Overlaying universe and intra-pathway microRNAs
with the Pathways in Cancer Network built for Figure 5, we see
that universe microRNAs have much higher degree than intra-
Figure 6. Micronome Roadmap. Network based on KEGG signalling pathways built on 3+DB microRNA interaction data. Universe microRNAs are
shown in red and intra-pathway microRNAs are in blue.
doi:10.1371/journal.pone.0017429.g006
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(p,0.0001) (Figure 7B). Considering that this type of effect
could have been induced by our filtering methods, we examined
our 3+DB interaction set for the number of targets predicted for
both universe and intra-pathway microRNAs. We did see
significantly more predicted targets for universe microRNAs
than for intra-pathway microRNAs (p,0.0001). However, this
distribution was replicated in TargetScan predicted targets
(p,0.0001), PITA predicted targets (p,0.0001) and picTar
predicted targets (p,0.0001) (Figure 7C). Since this distribution
transcends any filters that we have applied and it holds for these
individual database prediction sets we suggest that universe
microRNAs simply tend to have more targets, and are therefore
able to exert a broader program of control over the cell than are
intra-pathway microRNAs.
At this point, we would like to address the issue of bias in the
data and distinguish microRNA interaction sets from protein
interaction datasets. There is one large and obvious difference
between protein and microRNA interactions. Protein-protein
interactions are often curated through highly-biased information
gathering methods; literature searches, which are biased towards
highly-studied proteins, and high-throughput experiments focusing
on finding all partners for one protein of interest, while considering
a library of potential partners. Although useful interaction
generating techniques, they cannot be relied open to uncover
protein-protein interactions evenly across the proteome. Micro-
RNA:target relationships are different. The information upon
which our study is built is entirely sequence-based. The databases
considered do use different algorithms to make their predictions;
however, the predictions are free from bias due to the ground truth
that everything studied is sequence-based. Conservation of a
binding site, binding site accessibility and presence or absence of a
seed-region depend entirely on the coded gene, its transcribed
RNA and the sequence of the microRNA that might bind to it,
freeing us from the requirement to compensate for any bias in
microRNA:target predictions. That being said, one possible bias
that we cannot decouple from our current analysis is the
relationship of the length of a given gene’s 39 UTR and the
number of microRNAs that target it. It remains unclear if the fact
that genes with long 39 UTRs tend to have more predicted
targeting microRNAs is due to the fact that this is the way that the
biology works or if it is simply related to the odds of having more
binding sites in longer UTRs.
Finally, we examined the differences between universe and
intra-pathway microRNAs in a disease setting. First, we examined
the cumulative number of Online Mendelian Inheritance in Man
(OMIM) database [83] hits for all targets of each microRNA
(Figure 7D Top Panel). Arranging them in decreasing order we
show that universe microRNAs have many more OMIM hits than
do intra-pathway microRNAs. It should be noted here that we did
not normalize for number of targets per microRNA. The lower
panel shows the universe microRNAs having significantly more
cancer hits for each microRNA in the PhenomiR database [84]
compared to intra-pathway microRNAs (p,0.0001). We see a
strong distinction between universe microRNAs and intra-
pathway microRNAs for disease association, again supporting
our hypothesis that universe microRNAs are a subset of
microRNAs that can target many genes within the cell, acting as
master controls.
As further explanation for why universe microRNAs have been
more studied than intra-pathway microRNAs, a comparison of
microRNA ‘‘number’’ - their unique identifying IDs, which were
assigned in approximate order of discovery - shows that universe
microRNAs have a lower average identifying number than intra-
pathway microRNAs (mean ID for universe microRNAs=51 vs
intra-pathway microRNAs=84, p,0.0001).
This may be either because universe microRNAs have been
discovered earlier purely by chance and thus were more studied,
or they may truly be more universal and thus were easier to
discover under many conditions. To provide additional evidence
to answer this question, we considered expression of microRNAs
across a panel of tissues from Landgraf et al. [85]. Figure 8 shows a
heatmap comparing universe and intra-pathway microRNA
expression across tissues, confirming that universe microRNAs
are more widely expressed than intra-pathway microRNAs. Thus,
it is more likely that universe microRNAs are more broadly
affecting varying cell types, and through their misexpression,
universe microRNAs have the opportunity to create a more global
change quickly by affecting genes in many different pathways. To
further understand their role in human disease thus warrants
further research.
This work in microRNA interaction networks provides more
evidence for the possibility that microRNAs are in fact working in
a coordinated fashion with each other and within signalling
pathways. It has been previously noted that many microRNAs
might co-bind to a UTR [2,31,48,85], and perhaps our results
support that view, since genes in a common pathway share many
more common microRNAs than one would expect by chance
(p,0.0035 to p,0.365 for KEGG 2+DB). This thinking opens the
door for many exciting in vitro experiments to examine this co-
regulation and co-binding, and raises the questions, how many
microRNAs might actually be occupying a 39 UTR at once? Is it a
sequential or a parallel microRNA process? Future work to
determine the layout of such microRNA binding sites in the
untranslated regions might provide further insight here – and a
within pathway study of the degree of overlap and layout of
microRNA binding sites on interacting genes would provide
insight into the microRNA regulatory network. Another interest-
ing expansion of this work would be to determine predicted
binding sites in 59 UTRs and coding regions of target genes, and
integrate them with RNA22 predictions already included in
mirDIP to allow cross-database comparisons. While the majority
of confirmed microRNA binding sites fall into 39UTRs, fuctional
binding sites have been shown in other regions [86,87,88] and
attempts to include them in mirDIP would result in a more
complete representation of true microRNA target genes within the
cell.
The identification of two distinct classes of microRNAs –
universe and intra-pathway microRNAs – lays the frame work for
possibly hierarchical organization of pathway- and gene-level
control and execution of gene regulation. Using PhenomiR, we
provide the first disease-associated evidence that universe micro-
Figure 7. Comparison of universe and intra-pathway microRNAs. Panel A: Universe microRNAs have a significantly larger number of PubMed
papers compared to intra-pathway microRNAs (p=0.0002). Panel B: Universe microRNAs have significantly higher degree in the KEGG Pathways in
Cancer 3+DB network (p,0.0001). Panel C: Universe microRNAs have significantly more predicted target interactions than intra-pathway microRNA
across several different microRNA prediction databases (p,0.0001). Panel D: Top – Universe microRNA targets (red) tend to have more OMIM hits
than intra-pathway microRNAs (blue). Bottom – Universe microRNAs themselves have more ‘‘cancer’’ PhenomiR hits than intra-pathway microRNAs
(p,0.0001), supporting the result in panel B.
doi:10.1371/journal.pone.0017429.g007
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showing significantly more involvement in breast (p,0.07),
ovarian (p,0.005) and lung cancers (p,0.05) and in carcinogensis
overall (p,0.0001) while also showing involvement in human
disease in general (p,0.0001), and this information will allow us to
focus our disease-driven microRNA-associated research towards a
smaller subset of these potent cellular regulators.
Conclusions
MicroRNA Prediction Databases. Similar to work done by
other groups, we have examined microRNA prediction databases
to determine that PITA Top, picTar 5-way and Targetscan
Conserved provide the most accurate microRNA:target
predictions. Using different prediction algorithms, individual
predictions overlap only partially and they differ in their
precision and recall when compared to in vitro truth data.
However, each has a particular application where it might be
best suited for use. We have further examined the importance of
filtering target predictions before making microRNA database
comparisons, and have determined that filtering by both
experiment cell type and microarray chip type are crucial steps
that alter gene prediction sets by up to 40%. We suggest that when
searching for true microRNA targets, it is useful to consider such
steps.
mirDIP. We have presented a unique database to aid
researchers in determining the optimal microRNA prediction
databases to use for application-specific microRNA:target
searches. mirDIP allows users to focus their searches on any
Figure 8. Expression of universe and intra-pathway microRNAs. Universe microRNAs are expressed in a broader panel of tissues than intra-
pathway microRNAs [96].
doi:10.1371/journal.pone.0017429.g008
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precision’’ or ‘‘high recall’’ databases depending on their path of
study.
Discovery of Universe and Intra-pathway microRNAs in
Interaction Networks. Using data from mirDIP, we found
that microRNAs are significantly more involved in known
signalling pathways compared to random chance, producing
networks with more interactions (p,0.1 in 76% of tested
pathways). Signalling pathways contain many microRNAs that
target multiple elements of the pathway, perhaps suggesting a level
of transcriptional regulation not previously described. Our data
suggest a possible co-regulation of signalling proteins at the post-
transcriptional level – whether concurrent or sequential – which
opens new line of research to study hierarchical organization of
microRNAs. Further, we have identified two novel classes of
microRNAs: universe and intra-pathway microRNAs, which are
significantly differentiated by the degree of their involvement in
signalling pathways within the cell and their association with
cancer (p,0.0001) and human disease (p,0.0001). Universe
microRNAs are involved in regulation of many known signalling
pathways, while intra-pathway microRNAs are pathway-specific
and do not appear to play a global role in cellular regulation.
Materials and Methods
MicroRNA predictions were downloaded from the individual
microRNA prediction sites:
N http://microrna.org (Sept. 2008)
N http://microrna.sanger.ac.uk/targets/v5/(ver. 5) (now http://
ebi.ac.uk/enright-srv/microcosm/htdocs/targets/v5/)
N http://genie.weizmann.ac.il (ver. 6 Aug. 2008)
N http://cbcsrv.watson.ibm.com/rna22.html (Aug. 2007)
N http://targetscan.org (Release 5.0 Dec. 2008)
N http://pictar.mdc-berlin.de/(Mar. 2007)
N http://diana.cslab.ece.ntua.gr/microT/(V3.0)
Target Prediction Files
All target prediction files were processed to contain the same
information in the same format. The UCSC Genome Browser
(http://genome.ucsc.edu/) [89,90,91] and Galaxy [92,93] were
used to convert all files to include HUGO gene names for all
interactions according to human genome version hg18. RNA22,
picTar and DIANA microT required intermediate mapping steps
using Ens54 [94] and RefSeq May 2006 [95] assemblies. All files
were then combined to produce one file of all predictions. A
filtering step produced the interaction files for NAViGaTOR –
eliminating all interactions present in less than 2 or 3 microRNA
prediction databases. To avoid double-counting interactions
present in 2 databases from the same source compiled with
different stringency requirements, only the most stringent PITA
and picTar microRNA prediction files were used as inputs into the
integration and filtering steps.
microRNA microarray Truth Files
Files used to compare microRNA prediction files to truths were
obtained from the following GEO Datasets: GSE2075 [57],
GSM306946 [53], GSE6838/GSM155064 [58], GSE6207 [60],
GSM302945 [53], GSE13296 [54], GSE6838 [58], GSM302995
[53], GSE12091 [55], GSE9586 [59], GSE9742 [56], GSE14507,
GSE12092 [55]. Thresholds for low-, med- and high- confidence
truths were established using p-values of p,0.1, p,0.05, p,0.01,
where replicates were present, and otherwise at three step-wise
incremental knockdown or over-expression thresholds dependent
on the distribution of target knockdown – 50%-25%-10% for mir-
335 (GSE9586) and mir-7 (GSE14507) (in this case – since there
were only 2 replicates, we also required the replicates to be within
15% of each other), 75%-25%-10% for mir-155 (GSE13296) and
25%-20%-10% for mir-124 (GSE6207).
Target Filtering
To filter target predictions prior to prediction database
comparison, we used genes present in the bottom quartile of the
control cell line microarray experiment. In most cases, one or
more negative control sample values were present and those values
were averaged and then ranked by intensity value. When filtering
by experimental cell type, only genes not present in this bottom
quartile passed through our filter. In the few cases where it was not
possible to extract the control cell line values from the experiment
(mir-1 Lim et al. [5] and mir-124 Lim et al. [5]), filtering genes
from the negative controls from a microarray experiment in the
same cell line were used (mir-98 negative controls Gennarino et al.
[53]). We further filtered by the presence of the predicted target
gene on the microarray chip used in the experiment, information
available at GEO datasets.
NAViGaTOR Networks
NAViGaTOR networks [81,82] were built based on the
microRNA:target interaction files discussed above, with two
levels of robustness: interactions present in two or more databases
(2+DB) or interactions present in three or more databases
(3+DB). Note that out of the eleven databases examined in the
first section, only nine are used for the microRNA interaction
networks due to the fact that PITA Top Targets (used) is a subset
of PITA All Targets (not used) and picTar 5-way (used) is a subset
of picTar 4-way (not used). Using groups of Associated Genes of
interest (as determined by well known sub-units [69], pathways
extracted from the literature [66] and KEGG [70,71] and
Reactome [72,73,74] databases) as primary nodes – networks
were built to examine the interactions between the given
associated gene set at the microRNA level. Associated gene
network significance was evaluated based on four characteristics:
1) the number of nodes in the network, 2) the number of
interactions in the network, 3) the number of nodes with degree
greater than three, and 4) the measured network density, and
compared to values obtained from 2000 random networks
constructed from the same number of primary nodes (genes
randomly selected from the interaction file, hence genes that have
been identified as participating in a microRNA interaction by at
least two or three prediction databases). KEGG pathway HUGO
IDs were used to create networks, while Reactome Swiss Protein
IDs were mapped in the UCSC Genome Browser to HUGO IDs
before networks were built. Networks were built using the graph
(ver. 1.24.1) [78] and RBGL (ver. 1.22.0) packages [77] of the R
Statistical Package software (ver. 2.8.1) [76]. When comparing
pathways represented in both KEGG and Reactome databases,
comparisons were made between the differences of the sums of
the p-values of the four network parameters. All analysis was
done using NAViGaTOR ver. 2.1.13 [1] (http://ophid.utoronto.
ca/navigator).
Examination of Date and Party Hub Nodes
In our examination of human protein-protein interactions to
determine whether a bimodal date and party hub distribution was
present, I2D human source interactions were used [81,82].
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Using NAViGaTOR ver. 2.1.13 to display the microRNA:path-
way interactions from the KEGG 3+DB study, we laid out the
micronome roadmap to identify universe and intra-pathway
microRNAs. Comparisons between the two classes of microRNAs
and number of associated PubMed articles were done using
biopython (v1.50) (http://biopython.org). OMIM [83] hits and
PhenomiR (v1.0) [84] hits were drawn from their respective sources
(http://www.ncbi.nlm.nih.gov/omim/(accessed Feb. 2010) and
http://mips.helmholtz-muenchen.de/phenomir/).
Tarbase Comparison
We used Tarbase V5.0 [63] to compare our 2+DB interaction set
to the best curated set of microRNA interactions existing. We used
only human interactions, eliminated the support_type=FALSE
interactions and mapped by the HGNC column.
Details about mirDIP can be found in Methods S1.
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